Key result
PESI stratifies acute pulmonary embolism mortality, ranging from ~1% to ~25% across risk classes.
Why the study?
Does the Pulmonary Embolism Severity Index (PESI) accurately predict 30-day mortality and identify low-risk patients suitable for outpatient management in adults with acute pulmonary embolism?
Does the Pulmonary Embolism Severity Index (PESI) accurately predict 30-day mortality and identify low-risk patients suitable for outpatient management in adults with acute pulmonary embolism?
The PESI is a well-validated clinical decision tool that accurately predicts 30-day mortality in acute pulmonary embolism, safely guiding the selection of low-risk patients for outpatient management.
The Pulmonary Embolism Severity Index (PESI) is a risk stratification tool that has been externally validated to determine the mortality and outcome of patients with newly diagnosed PE.
No takes yet. Share an insight, caveat, or question.
Miranda Bradley (2026) conducted a review in Acute Pulmonary Embolism (n=15,531). Pulmonary Embolism Severity Index (PESI) was evaluated on 30-day mortality. The Pulmonary Embolism Severity Index (PESI) effectively stratified patients with acute pulmonary embolism into five risk classes, with 30-day mortality ranging from 1.1% in very low-risk to 24.5% in very high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: